Zhou Lihan

Lihan is the Founder and co-CEO of ark. In 2014, Lihan co-founded and served as CEO of MiRXES, a biotech startup developing microRNA technologies and cancer detection tests. He oversaw MiRXES’ operations in Singapore and China, and managed collaborations with leading clinical consortia and pharmaceutical companies in developing microRNA based diagnostic assays. MIRXES was recognized as Singapore’s Most Promising Startup 2016 by the Emerging Enterprise Award. Prior to founding MiRXES, Lihan was a research scientist at the Bioprocessing Technology Institute, A*STAR where he co-developed a novel microRNA qPCR assay platform and an integrated workflow for biomarker discovery. Lihan has a PhD in Biochemistry from the National University of Singapore. He has authored and co-authored more than 20 peer-reviewed publications and 8 patent applications. Lihan was recently recognized by the MIT Technology Review as a member of the Innovators Under 35.

Zhou Lihan is the Co-Founder, Director, and Chief Executive Officer at Mirxes, based in Asia. With a background in Biotechnology, Zhou Lihan has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.